Skip to main content

Table 2 Echocardiographic parameters of the study group

From: Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease

 

Skin AF ≤2.2

Skin AF >2.2

P value

LVEF (%)

68.80 ± 7.20

65.82 ± 8.11

0.02

LA diameter (mm)

35.34 ± 4.01

38.91 ± 4.72

0.01

E (cm/s)

74.88 ± 15.62

74.37 ± 19.16

0.86

A (cm/s)

87.94 ± 22.28

93.80 ± 20.60

0.11

E/A ratio

0.89 ± 0.26

0.82 ± 0.24

0.11

E’(SW) (cm/s)

7.54 ± 2.13

6.17 ± 1.84

0.01

A’(SW) (cm/s)

10.11 ± 2.08

9.44 ± 2.10

0.06

E/E’ ratio

10.73 ± 3.81

12.90 ± 4.50

0.01

DT (ms)

212.44 ± 42.20

227.85 ± 51.90

0.06

LVMI (g/m2.7)

47.72 ± 11.62

61.22 ± 17.76

0.01

oLVM/pLVM

1.21 ± 0.21

1.62 ± 0.38

0.01

  1. Skin AF skin autofluorescence, LVEF left ventricular ejection fraction, LA left atrium, E early diastolic peak velocity, A late diastolic peak velocity, E′ early diastolic peak velocity at septal portion of mitral annulus, A′ late diastolic peak velocity at septal portion of mitral annulus, SW septal wall, DT deceleration time, LVMI left ventricular mass index, oLVM observed left ventricular mass, pLVM predicted left ventricular mass
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840